(Q46043845)

English

Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits

scientific article published on 17 September 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Formulation of HIV-1 Tat and p24 antigens by PLA nanoparticles or MF59 impacts the breadth, but not the magnitude, of serum and faecal antibody responses in rabbits (English)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Christophe Guillon

1

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Katia Mayol

2

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Céline Terrat

3

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Christelle Compagnon

4

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Charlotte Primard

5

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Marie-Hélène Charles

6

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Thierry Delair

7

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Séverine Munier

8

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Bernard Verrier

9

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

language of work or name

0 references

publication date

17 September 2007

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

number of pages

11

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

25

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

43

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

7491-7501

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

Whole-cell but not acellular pertussis vaccines induce convulsive activity in mice: evidence of a role for toxin-induced interleukin-1beta in a new murine model for analysis of neuronal side effects of vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Immunity in response to particulate antigen-delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Mucosal immunisation: adjuvants and delivery systems.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Vaccine adjuvants: role and mechanisms of action in vaccine immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Controlled delivery of diphtheria toxoid using biodegradable poly(D,L-lactide) microcapsules

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Immune response to nasal delivery of antigenically intact tetanus toxoid associated with poly(L-lactic acid) microspheres in rats, rabbits and guinea-pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Strong T cell type-1 immune responses to HIV-1 Tat (1-72) protein-coated nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Immunogenicity of single-dose diphtheria vaccines based on PLA/PLGA microspheres in guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Formulation aspects of biodegradable polymeric microspheres for antigen delivery

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Polylactide-co-glycolide microparticles with surface adsorbed antigens as vaccine delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Surfactant-free anionic PLA nanoparticles coated with HIV-1 p24 protein induced enhanced cellular and humoral immune responses in various animal models.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Coadsorption of HIV-1 p24 and gp120 proteins to surfactant-free anionic PLA nanoparticles preserves antigenicity and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

MF59-adjuvanted vaccines: increased immunogenicity with an optimal safety profile

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

A preliminary evaluation of alternative adjuvants to alum using a range of established and new generation vaccine antigens

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Design and characterization of an HIV-1 Tat mutant: inactivation of viral and cellular functions but not antigenicity.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Overexpression of HIV-1 proteins in Escherichia coli by a modified expression vector and their one-step purification.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Evidence for CTL-mediated selection of Tat and Rev mutants after the onset of the asymptomatic period during HIV type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

HIV-1 Tat-coated nanoparticles result in enhanced humoral immune responses and neutralizing antibodies compared to alum adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

DNA prime and protein boost immunization with innovative polymeric cationic core-shell nanoparticles elicits broad immune responses and strongly enhance cellular responses of HIV-1 tat DNA vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

HIV-1 Tat is a natively unfolded protein: the solution conformation and dynamics of reduced HIV-1 Tat-(1-72) by NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Full-length HIV-1 Tat protein necessary for a vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2007.08.060

7 January 2021

Identifiers

10.1016/J.VACCINE.2007.08.060

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

19 December 2017

http://europepmc.org/abstract/MED/17904700

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46043845&oldid=2089330302"